Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INDAO: Glyburide vs Insulin in Gestational Diabetes
NCT01731431Phase 3Completed
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- May 2012
- Primary completion
- Mar 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of glibenclamide in gestational diabetes mellitus (GDM) (2 arms), sponsored by Assistance publique - Hôpitaux de Paris. Primary endpoint: Composite criterion of neonatal complications associated with gestational diabetes. Started May 2012; status: completed.
02
Drugs
glibenclamide
03
Conditions
gestational diabetes mellitus (GDM)
Beyond the preview
Go deeper on NCT01731431.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01731431.